BioSpace News Archive

Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, today announced that it will present at the American Society of Gene and Cell Therapy (ASGCT) 25th Annual Meeting.

Lexicon Pharmaceuticals, Inc., announced that results of a new investigator-initiated economic analysis, based on results from the SOLOIST-WHF Phase 3 outcomes study of its investigational medicine sotagliflozin, were presented on May 9 at the International Society for Pharmacoeconomics and Outcomes Research annual meeting in Boston, Massachusetts.

STERIS plc announced financial results for its fiscal 2023 fourth quarter and full year ended March 31, 2023.

Belite Bio, Inc. announced its financial results for the first quarter ended March 31, 2023 and provided a general business update.

Zevra Therapeutics, Inc. today announced that R. LaDuane Clifton, the Company’s Chief Financial Officer, will present at the RBC Capital Markets Global Healthcare Conference on Tuesday, May 16, 2023, at 3:05 p.m. ET.

Bluejay Diagnostics, Inc. today announced financial results for the quarter ended March 31, 2023.

Avalyn Pharma Inc. today announced that Lyn Baranowski , CEO, is planning to present a corporate update during the BioEquity Europe conference being held May 14-16, 2023.

Korro Bio, a leading RNA editing company focused on the discovery and development of novel genetic medicines, today announced the appointment of Shelby Walker, JD, as Senior Vice President and General Counsel.

FSD Pharma Inc. today announced the completion of dosing the first cohort of patients in the Company’s Phase I clinical trial of Lucid-21-302 (“Lucid-MS”).

Capsida Biotherapeutics (“Capsida”) today announced it will present preliminary data on the company’s next-generation engineered adeno-associated virus (AAV) capsids in non-human primates.